Denisovan, modern human and mouse alleles tune A20 phosphorylation and immunity

Journal: Nature Immunology

Published: 2019-09-18

DOI: 10.1038/s41590-019-0492-0

Affiliations: 23

Authors: 56

Go to article
Institutions Share
Garvan Institute of Medical Research, Australia 0.24
ANU John Curtin School of Medical Research (JCMSR), Australia 0.15
Faculty of Medicine, UNSW Sydney, Australia 0.12
Genentech, Inc., United States of America (USA) 0.07
Children's Hospital at Westmead (CHW), USYD, Australia 0.06
ANU Research School of Chemistry, Australia 0.05
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.05
Department of Biochemistry and Molecular Biology, Monash University, Australia 0.04
Center for Infectious Disease Research (CIDR), United States of America (USA) 0.03
Stanford Department of Microbiology and Immunology, United States of America (USA) 0.03
School of Women's and Children's Health (SPHCM), UNSW Sydney, Australia 0.03
UNC Eshelman School of Pharmacy, United States of America (USA) 0.02
Department of Pathology, CWRU, United States of America (USA) 0.02
Sydney Children's Hospital, Randwick, Australia 0.02
Institute of Fundamental Sciences, Massey University, New Zealand 0.02
School of Biotechnology and Biomolecular Sciences (BABS), UNSW Sydney, Australia 0.01
College of Medicine and Public Health, Flinders University, Australia 0.01
ANU Research School of Population Health (RSPH), Australia 0.01
School of Medicine, UTAS, Australia 0.01
Snyder Institute for Chronic Diseases, U of C, Canada 0.01
Celgene Corporation, United States of America (USA) 0.01